Literature DB >> 8618050

Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers.

M Weckroth1, A Vaheri, J Lauharanta, T Sorsa, Y T Konttinen.   

Abstract

Although extracellular proteolysis is a prerequisite for normal wound healing, uncontrolled proteolytic tissue destruction appears to be a pathogenic factor in non-healing wounds. The aim of our study was to compare the activities of the serine proteinases of polymorphonuclear origin, elastase and cathepsin G, and the metalloproteinases, gelatinase and collagenase, in chronic leg ulcer exudate (10 patients) and acute wound fluid (6 patients). Serine proteinase activities were low in leg ulcer exudates but very high in some but not all acute wound fluids. Total collagenase activity, measured as activity against type I collagen monitored by SDS-PAGE and densitometry, was higher in chronic leg ulcer exudate than in acute wound fluid and its degree of autoactivation was relatively high. Doxycycline inhibition studies suggested that the collagenase activity in chronic leg ulcer exudate was MMP-1 ("fibroblast-type") and not MMP-8 ("neutrophil-type"). Zymographic analysis of the gelatinolytic enzymes in acute wound fluid showed a progressive increase from the day of operation to postoperative day 5, but the degree of activity was lower than in chronic leg ulcer exudate and the low molecular mass activation products were faint. The leg ulcer gelatinase profiles were characterized by high expression of 92/82- and 72/62-kDa duplex bands and by the presence of low molecular mass activation products. Leg ulcer collagenase seems to be derived from mononuclear rather than polymorphonuclear cells, which are known to be involved in acute wound healing. In conclusion, the present study shows that gelatinase and collagenase, but not elastase and cathepsin G are found in chronic leg ulcer exudate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8618050     DOI: 10.1111/1523-1747.ep12340167

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  33 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Gene therapy and wound healing.

Authors:  Sabine A Eming; Thomas Krieg; Jeffrey M Davidson
Journal:  Clin Dermatol       Date:  2007 Jan-Feb       Impact factor: 3.541

3.  Therapeutic failure in American cutaneous leishmaniasis is associated with gelatinase activity and cytokine expression.

Authors:  A C Maretti-Mira; M P de Oliveira-Neto; A M Da-Cruz; M P de Oliveira; N Craft; C Pirmez
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

4.  Age-related reduction of dermal fibroblast size upregulates multiple matrix metalloproteinases as observed in aged human skin in vivo.

Authors:  Z Qin; R M Balimunkwe; T Quan
Journal:  Br J Dermatol       Date:  2017-11-01       Impact factor: 9.302

5.  Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts.

Authors:  Andreea M Bujor; Sashidar Nakerakanti; Erin Morris; Faye N Hant; Maria Trojanowska
Journal:  Exp Dermatol       Date:  2010-02-25       Impact factor: 3.960

6.  In vitro and in vivo studies on matrix metalloproteinases interacting with small intestine submucosa wound matrix.

Authors:  Lei Shi; Sarah Ramsay; Ryan Ermis; Dennis Carson
Journal:  Int Wound J       Date:  2011-08-31       Impact factor: 3.315

Review 7.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 8.  Wound samples: moving towards a standardised method of collection and analysis.

Authors:  Sarah Ramsay; Linda Cowan; Jeffrey M Davidson; Lillian Nanney; Gregory Schultz
Journal:  Int Wound J       Date:  2015-01-11       Impact factor: 3.315

9.  Matrix metalloproteinase-9 delays wound healing in a murine wound model.

Authors:  Matthew J Reiss; Yan-Ping Han; Edwin Garcia; Mytien Goldberg; Hong Yu; Warren L Garner
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

10.  A pilot study evaluating protein abundance in pressure ulcer fluid from people with and without spinal cord injury.

Authors:  Laura E Edsberg; Jennifer T Wyffels; Rajna Ogrin; B Catharine Craven; Pamela Houghton
Journal:  J Spinal Cord Med       Date:  2014-06-26       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.